VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
1.250
-0.050 (-3.85%)
At close: May 12, 2025, 4:00 PM
1.280
+0.030 (2.40%)
After-hours: May 12, 2025, 6:19 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $18.54 million as of May 12, 2025. Its market cap has decreased by -48.84% in one year.
Market Cap
18.54M
Enterprise Value
-31.67M
1-Year Change
-48.84%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $18.54M, a decrease of -91.93%. That is a compound annual growth rate of -38.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 19.28M | -60.99% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |